S&P 500
(1.13%) 5 105.34 points
Dow Jones
(0.51%) 38 282 points
Nasdaq
(2.03%) 15 929 points
Oil
(0.22%) $83.75
Gas
(-1.16%) $1.619
Gold
(0.38%) $2 351.30
Silver
(-0.08%) $27.33
Platinum
(0.29%) $923.15
USD/EUR
(0.27%) $0.934
USD/NOK
(0.62%) $11.02
USD/GBP
(0.08%) $0.800
USD/RUB
(-0.34%) $91.86

Realtime updates for Indivior PLC [INDV.L]

Exchange: LSE Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated26 Apr 2024 @ 11:35

0.57% £ 1 408.00

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 11:35):

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders...

Stats
Today's Volume 679 546
Average Volume 506 520
Market Cap 1.91B
EPS £0 ( 2024-04-24 )
Next earnings date ( £0 ) 2024-07-25
Last Dividend £36.50 ( 2016-06-16 )
Next Dividend £0 ( N/A )
P/E 1 408.00
ATR14 £2.32 (0.16%)

Volume Correlation

Long: 0.13 (neutral)
Short: 0.16 (neutral)
Signal:(49.655) Neutral

Indivior PLC Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Indivior PLC Correlation - Currency/Commodity

The country flag 0.54
( weak )
The country flag 0.82
( strong )
The country flag -0.65
( weak negative )
The country flag 0.07
( neutral )
The country flag 0.16
( neutral )
The country flag 0.74
( moderate )

Indivior PLC Financials

Annual 2023
Revenue: £1.09B
Gross Profit: £907.00M (82.98 %)
EPS: £0.0100
FY 2023
Revenue: £1.09B
Gross Profit: £907.00M (82.98 %)
EPS: £0.0100
FY 2022
Revenue: £901.00M
Gross Profit: £742.00M (82.35 %)
EPS: £-0.380
FY 2021
Revenue: £791.00M
Gross Profit: £664.00M (83.94 %)
EPS: £1.410

Financial Reports:

No articles found.

Indivior PLC Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)
£0
(N/A)

Indivior PLC Dividend Information - Ex Dividend Junior

Dividend Sustainability Score: 4.95 - low (64.48%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend £10.40 2015-09-17
Last Dividend £36.50 2016-06-16
Next Dividend £0 N/A
Payout Date 2016-07-29
Next Payout Date N/A
# dividends 2 --
Total Paid Out £46.90 --
Avg. Dividend % Per Year 0.00% --
Score 1.12 --
Div. Sustainability Score 4.95
Div.Growth Potential Score 0
Div. Directional Score 1.992 --
Next Divdend (Est)
(2024-07-15)
£0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
1.12
Pay Frequency
Annually
Yearly Payout
Year Amount Yield
2015 £0 0.00%
2016 £0 0.00%
2017 £0 0.00%
2018 £0 0.00%
2019 £0 0.00%
2020 £0 0.00%
2021 £0 0.00%
2022 £0 0.00%
2023 £0 0.00%
2024 £0 0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for LSE

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
SPI.L Dividend Junior 2023-05-25 Annually 10 0.18%
JHD.L Dividend King 2023-05-11 Semi-Annually 32 1.47%
CAML.L Dividend Knight 2023-09-28 Annually 12 3.83%
PMP.L Dividend Junior 2023-11-16 Annually 32 1.59%
GBG.L Dividend Junior 2023-06-22 Annually 22 0.51%
AJB.L Dividend Knight 2023-06-08 Semi-Annually 6 1.30%
TFIF.L Dividend Knight 2023-07-20 Quarterly 12 4.62%
LRE.L Dividend Knight 2023-08-17 Semi-Annually 16 1.26%
COA.L Dividend Knight 2023-10-19 Annually 33 1.79%
RHIM.L Dividend Knight 2023-08-24 Annually 7 3.49%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.001831.5009.9610.00[0 - 0.5]
returnOnAssetsTTM0.001021.2009.9710.00[0 - 0.3]
returnOnEquityTTM0.005421.500-1.051-1.576[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM0.9680.800-0.161-0.129[1 - 3]
quickRatioTTM0.5260.800-1.609-1.287[0.8 - 2.5]
cashRatioTTM0.2421.5009.7710.00[0.2 - 2]
debtRatioTTM0.144-1.5007.59-10.00[0 - 0.6]
interestCoverageTTM0.5531.000-0.906-0.906[3 - 30]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
freeCashFlowPerShareTTM-2.682.00-1.339-2.68[0 - 20]
debtEquityRatioTTM0.215-1.5009.14-10.00[0 - 2.5]
grossProfitMarginTTM0.8301.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM0.01921.000-1.616-1.616[0.1 - 0.6]
cashFlowToDebtRatioTTM-1.1171.000-7.32-7.32[0.2 - 2]
assetTurnoverTTM0.5590.8009.607.68[0.5 - 2]
Total Score4.95

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM1 202.591.00010.000[1 - 100]
returnOnEquityTTM0.005422.50-0.676-1.576[0.1 - 1.5]
freeCashFlowPerShareTTM-2.682.00-0.892-2.68[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-2.292.00-0.764-1.528[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM01.500-3.330[0.5 - 2]
operatingCashFlowSalesRatioTTM-0.2881.000-9.700[0.1 - 0.5]
Total Score-0.971

Indivior PLC

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex. The company operates in approximately 40 countries worldwide. Indivior PLC has research collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators